Kolexia
Brouchet Laurent
Chirurgie vasculaire
Hôpital Larrey Toulouse
Toulouse, France
107 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Complications postopératoires Carcinomes Thorax en entonnoir Carcinome épidermoïde Mésothéliome Urgences

Industries

AstraZeneca
27 collaboration(s)
Dernière en 2023
BARD FRANCE SAS
5 collaboration(s)
Dernière en 2022
Intuitive Surgical
5 collaboration(s)
Dernière en 2023
MSD
4 collaboration(s)
Dernière en 2023

Dernières activités

Combination of electromagnetic navigation and probe-based LASER endomicroscopy to guide non-solid nodules sampling: Results from the CELTICS 2 study.
Respiratory medicine and research   28 février 2024
Protective effect of height on long-term survival of resectable lung cancer: a new feature of the lung cancer paradox.
Thorax   15 février 2024
Impact of surgical approach on 90-day mortality after lung resection for nonsmall cell lung cancer in high-risk operable patients.
ERJ open research   22 janvier 2024
Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer.
Frontiers in oncology   22 novembre 2023
MA08.04 Assessment of the Quality of the Surgical Procedure and the Operative Report Based on Nationwide French Registry: A RYTHMIC study
Abstracts from the 2023 World Conference on Lung Cancer   01 novembre 2023
A 3D-engineered silicone stent to treat a refractory bronchopleural fistula.
ERJ open research   13 mars 2023
IONESCO: A Phase II Prospective Immune Neoadjuvant Therapy Study od Durvalumab (MEDI4736) in Early Stage Non-small Cell Lung Cancer
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   10 mars 2023
Reaching multidisciplinary consensus on the management of non-bulky/non-infiltrative stage IIIA N2 non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands)   18 janvier 2023
N2-3S: Molecular Signature From Tumor to Lymph Nodes: How to Identify the Right Candidate for IIIA-N2 Lung Cancer Surgery?
Essai Clinique (Assistance publique – Hôpitaux de Paris)   06 janvier 2023
Prognostic score and sex-specific nomograms to predict survival in resectable lung cancer: A French nationwide study from the Epithor cohort database.
The Lancet regional health. Europe   19 décembre 2022